Northpond Ventures
41 portfolio companies · 9 on the map · $727.8M raised · 8 cities
Portfolio map
9 Northpond Ventures portfolio companies on the map.
Portfolio companies

DELFI Diagnostics
Palo Alto
Delfi Diagnostics detects cancer early, when it is most curable, using high precision non-invasive blood tests.
Medical and Diagnostic Laboratories$364.8MEst. 2019
908 Devices
Burlington
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
Manufacturing$167.8MEst. 2012
Eleanor Health
Worcester
Eleanor Health provides comprehensive mental health and substance use disorder care in clinics, virtually, and in patient's homes.
Hospitals and Health Care$115.1MEst. 2019
Outcomes4Me
Boston
Outcomes4Me develops direct-to-patient AI-driven platform designed to assist cancer patients in managing their care.
Wellness and Fitness Services$37.7MEst. 2017
Faro Health
San Diego
Faro Health is a company that handles the tedious work better left for a computer.
Software Development$35MEst. 2019
Molecule
Schaffhausen
Molecule is a software platform used to accelerate innovation in the pharmaceutical industry.
Biotech$6.6MEst. 2020
Octave
Mechelen
Mechelen-based · energy.
Energy$750KEst. 2020- SD
Selux Diagnostics
Boston
SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.
Biotechnology ResearchSeries DEst. 2014 
Culture Biosciences
South San Francisco
Culture is a cloud-based bioreactor lab that accelerates bioprocess development by letting customers design experiments and have Culture execute them in its high-throughput bioreactor cloud lab, with real-time data monitoring and analytics
BiotechnologySeries CEst. 2016
More portfolio companies
32 more Northpond Ventures investments we track beyond the map.
VizgenCambridge · Series E
ElephasMadison · Venture
Vigil NeuroscienceCambridge · Series B
EmulateBoston · Series E
DNAnexusMountain View · Series H
Aro BiotherapeuticsPhiladelphia · Series B
VestaronDurham · Series C
Sherlock BiosciencesCambridge · Series B
OMass TherapeuticsOxford · Series B
InflammatixBurlingame · Series E
Code BiotherapeuticsHatfield · Series A
KytopenCambridge · Series A
Vital BioToronto · Series A
VieCureDenver · Venture
Current HealthBoston · Series B
1859San Diego · Series A
Transition BioCambridge · Series A
Stratus TherapeuticsCambridge · Series A
Totus MedicinesCambridge · Series B
RefeynOxford · Series A
IsoPlexisBranford · Series C
Ori BiotechLondon · Series B
SimBioSysChicago · Series A
SyapseSan Francisco · Venture
Triumvira ImmunologicsAustin · Series A
Telesis BioSan Diego · Post-IPO Equity
Walking Fish TherapeuticsSan Francisco · Series A
Nanoview BiosciencesBoston · Series B
PerceivMontréal · Seed
General Automation Lab TechnologiesSan Carlos · Series A
Story HealthCupertino · Series A
TeckroNew York · Series C
Portfolio map
9 Northpond Ventures portfolio companies on the map.